PROFESSIONAL EDITION

The largest community of pharma leaders

Look Who’s On the Move!

Abond CRO Announces That Mr. Zoran Antonijevic Is Their New Vice President, Statistical Consulting

ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, Chief Executive Officer and Vice President, is pleased to announced today that Zoran Antonijevic is the Vice President, Statistical...

Zoetis Receives European Commission Marketing Authorization for Solensia® (frunevetmab), a New Therapy for Feline Osteoarthritis Pain

ZAVENTEM, Belgium--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the marketing authorization for Solensia® (frunevetmab), a new feline osteoarthritis treatment...

Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D

TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced Ken Takeshita, MD will be named the new...

LAVA Therapeutics Appoints Dr. Kapil Dhingra as Chairman of the Board of Directors in Advance of Lead Program Entering the Clinic

UTRECHT, The Netherlands & PHILADELPHIA--(BUSINESS WIRE)--LAVA Therapeutics B.V., an early clinical-stage biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers...

Recent Articles